New Blood Thinning Drug Launched in Britain

by Kathy Jones on  September 5, 2011 at 7:43 PM Drug News
RSS Email Print This Page Comment
Font : A-A+

The first blood thinning drug to be approved in more than five decades for stroke patients has been launched in Britain and is expected to help more than 1.2 million patients in the country.
 New Blood Thinning Drug Launched in Britain
New Blood Thinning Drug Launched in Britain

Recently concluded trial studies of the drug dabigatran etexilate, which will be marketed as Pradaxa, have shown that it reduces the risk of stroke by almost 39 percent among patients suffering from atrial fibrillation.

Experts believe that while Pradaxa is considerably more expensive than the currently available drug warfarin, it is more effective than the latter and there is no danger of accidently giving the wrong dose.

"This new medication appears to be very promising. However, it's important to note that it won't be suitable for all, and every AF patient needs to be treated on a case-by-case basis to ensure that they receive the best possible treatment for them", Chief executive of the Stroke Association, Jon Barrick said.


Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Thalassemia Signature Drug Toxicity Blood in Stools - Symptom Evaluation Bombay Blood Group 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive